Evaluations of Alkyl hydroperoxide reductase B cell antigen epitope as a potential epitope vaccine against Campylobacter jejuni

[1]  D. Barh,et al.  An In Silico Identification of Common Putative Vaccine Candidates against Treponema pallidum: A Reverse Vaccinology and Subtractive Genomics Based Approach , 2017, International journal of molecular sciences.

[2]  A. Ebihara,et al.  In silico proposition to predict cluster of B- and T-cell epitopes for the usefulness of vaccine design from invasive, virulent and membrane associated proteins of C. jejuni , 2016, In Silico Pharmacology.

[3]  M. Hänninen,et al.  Antimicrobial Resistance Profiles of Campylobacter spp. Isolated from Broiler Chicken Meat of Estonian, Latvian and Lithuanian Origin at Estonian Retail Level and from Patients with Severe Enteric Infections in Estonia , 2016, Zoonoses and public health.

[4]  Yeonhee Lee,et al.  First Report and Molecular Characterization of a Campylobacter jejuni Isolate with Extensive Drug Resistance from a Travel-Associated Human Case , 2015, Antimicrobial Agents and Chemotherapy.

[5]  Felipe Del Canto,et al.  Vaccines for viral and bacterial pathogens causing acute gastroenteritis: Part II: Vaccines for Shigella, Salmonella, enterotoxigenic E. coli (ETEC) enterohemorragic E. coli (EHEC) and Campylobacter jejuni , 2015, Human vaccines & immunotherapeutics.

[6]  Felipe Del Canto,et al.  Vaccines for viral and bacterial pathogens causing acute gastroenteritis: Part I: Overview, vaccines for enteric viruses and Vibrio cholerae , 2015, Human vaccines & immunotherapeutics.

[7]  P. Karplus,et al.  Tuning of Peroxiredoxin Catalysis for Various Physiological Roles , 2014, Biochemistry.

[8]  P. Guerry,et al.  A capsule conjugate vaccine approach to prevent diarrheal disease caused by Campylobacter jejuni , 2014, Human vaccines & immunotherapeutics.

[9]  Euna Oh,et al.  Role of Alkyl Hydroperoxide Reductase (AhpC) in the Biofilm Formation of Campylobacter jejuni , 2014, PloS one.

[10]  K. Stark,et al.  Epidemiology of campylobacteriosis in Germany – insights from 10 years of surveillance , 2014, BMC Infectious Diseases.

[11]  D. Kelleher,et al.  Alkyl hydroperoxide reductase: a candidate Helicobacter pylori vaccine. , 2012, Vaccine.

[12]  R. Inman,et al.  Immunodominance: a pivotal principle in host response to viral infections. , 2012, Clinical immunology.

[13]  Herbert L DuPont,et al.  Clinical practice. Bacterial diarrhea. , 2009, The New England journal of medicine.

[14]  R. Rappuoli,et al.  Genome‑based vaccine development: A short cut for the future , 2008, Human vaccines.

[15]  N. Husain,et al.  Differences in virulence attributes between cytolethal distending toxin positive and negative Campylobacter jejuni strains. , 2008, Journal of medical microbiology.

[16]  A. Klančnik,et al.  Environmental stress factors affecting survival and virulence of Campylobacter jejuni. , 2007, Microbial pathogenesis.

[17]  John E. Linz,et al.  C57BL/6 and Congenic Interleukin-10-Deficient Mice Can Serve as Models of Campylobacter jejuni Colonization and Enteritis , 2006, Infection and Immunity.

[18]  K. Killeen,et al.  Live, attenuated Salmonella typhimurium vectoring Campylobacter antigens. , 2006, Vaccine.

[19]  J. Imlay,et al.  Alkyl Hydroperoxide Reductase Is the Primary Scavenger of Endogenous Hydrogen Peroxide in Escherichia coli , 2001, Journal of bacteriology.

[20]  T. Trust,et al.  Evaluation of a Truncated Recombinant Flagellin Subunit Vaccine against Campylobacter jejuni , 1999, Infection and Immunity.

[21]  N. Chaika.  [Epidemiology of campylobacteriosis]. , 1983, Zhurnal mikrobiologii, epidemiologii, i immunobiologii.